[1] Zhu N, Zhang D, Wang W, et al. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020, 382(8): 727-733.
[2] Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395(10223): 514-523.
[3] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析.中华流行病学杂志, 2020, 41(2): 145-151.
[4] Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis, 2020, 92: 214-217.
[5] 国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒感染的肺炎诊疗方案(试行第七版).(2020-03-03)[2020-03-03].
[6] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet, 2020, 395(10223): 507-513.
[7] 关贵文,高林,王建文,等. 新型冠状病毒感染肺炎患者肝酶异常的机制探讨.中华肝脏病杂志,2020 ,28(2):100-106.
[8] 胡利琳,王炜珺,朱清静,等. 新型冠状病毒感染肺炎相关肝损伤:病因分析及治疗策略.中华肝脏病杂志,2020,28(2):97-99.
[9] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506.
[10] 汪姝惠, 韩平, 肖芳, 等. 新型冠状病毒肺炎住院患者333例的肝损伤表现.中华消化杂志,2020, 40 (3):292-295.
[11] Shimabukuro-Vornhagen A, G?del P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer, 2018, 6(1):56.
[12] Betakova T, Kostrabova A, Lachova V, et al. Cytokines induced during influenza virus infection. Curr Pharm Des, 2017, 23(18):2616-2622.
[13] 刘川, 江自成, 邵初晓. 等.新型冠状病毒肺炎与肝功能损伤的关系初探:一项多中心研究. 中华肝脏病杂志, 2020, 28(2): 107-111.
[14] Iorga A, Dara L. Cell death in drug-induced liver injury. Adv Pharmacol, 2019,85:31-74. |
